calendar

3 catalysts · 1 phase 1 initiation · 1 phase 2 completion · 1 phase iv trial initiation

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

sort

soonest latest type sponsor alpha

TA: immunology×to 2026-04-24×clear all

type

phase 1 initiation1
phase 2 completion1
phase iv trial initiation1

therapy area

Oncology9
Infectious Disease5
Dermatology4

Week of Apr 20, 2026

›Apr 24, 2026phase 1 initiation109d agoBeijing Friendship Hospital — CMSD-001 (Phase I Trial Initiation)CMSD-001

Therapy area: Dermatology, Immunology. Indication: Atopic Dermatitis (Atopic Eczema), Plaque Psoriasis (Psoriasis Vulgaris), Systemic Lupus Erythematosus

full page →CMSD-001 →source: globaldata

›Apr 24, 2026phase 2 completion109d agoAlentis Therapeutics AG — lixudebart (Phase II Trial Completion)lixudebart

Therapy area: Genito Urinary System, Immunology. Indication: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis), Glomerulonephritis, Kidney Fibrosis

full page →lixudebart →source: globaldata

›Apr 24, 2026phase iv trial initiation109d agoAll India Institute of Medical Sciences Jodhpur — melatonin (Phase IV Trial Initiation)melatonin

Therapy area: Central Nervous System, Immunology. Indication: Delirium, Inflammation

full page →melatonin →source: globaldata